Lønning PE - Search Results

1

Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications.

Kristensen VN, Sørlie T, Geisler J, Langerød A, Yoshimura N, Kåresen R, Harada N, Lønning PE, Børresen-Dale AL. Kristensen VN, et al. Among authors: lonning pe. Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):878s-83s. Clin Cancer Res. 2005. PMID: 15701881 Review.

2

Influence of droloxifene (3-hydroxytamoxifen), 40 mg daily, on plasma gonadotrophins, sex hormone binding globulin and estrogen levels in postmenopausal breast cancer patients.

Geisler J, Ekse D, Hösch S, Lønning PE. Geisler J, et al. Among authors: lonning pe. J Steroid Biochem Mol Biol. 1995 Nov;55(2):193-5. doi: 10.1016/0960-0760(95)00163-t. J Steroid Biochem Mol Biol. 1995. PMID: 7495698 Clinical Trial.

3

Influence of treatment with the anti-oestrogen 3-hydroxytamoxifen (droloxifene) on plasma sex hormone levels in postmenopausal patients with breast cancer.

Geisler J, Haarstad H, Gundersen S, Raabe N, Kvinnsland S, Lønning PE. Geisler J, et al. Among authors: lonning pe. J Endocrinol. 1995 Aug;146(2):359-63. doi: 10.1677/joe.0.1460359. J Endocrinol. 1995. PMID: 7561649 Clinical Trial.

4

[Mistletoe in the treatment of cancer].

Kvinnsland S, Kåresen R, Lønning PE, Søreide JA. Kvinnsland S, et al. Among authors: lonning pe. Tidsskr Nor Laegeforen. 1993 Aug 10;113(18):2284-5. Tidsskr Nor Laegeforen. 1993. PMID: 7741807 Norwegian. No abstract available.

5

[Endocrine therapy of progressive breast carcinoma].

Geisler J, Wiedemann GJ, Lønning PE. Geisler J, et al. Among authors: lonning pe. Dtsch Med Wochenschr. 1995 Feb 24;120(8):263-7. doi: 10.1055/s-2008-1055342. Dtsch Med Wochenschr. 1995. PMID: 7867484 Review. German. No abstract available.

6

Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer.

Lønning PE, Helle SI, Johannessen DC, Ekse D, Adlercreutz H. Lønning PE, et al. Breast Cancer Res Treat. 1996;39(3):335-41. doi: 10.1007/BF01806162. Breast Cancer Res Treat. 1996. PMID: 8877014

7

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer.

Geisler J, King N, Dowsett M, Ottestad L, Lundgren S, Walton P, Kormeset PO, Lønning PE. Geisler J, et al. Among authors: lonning pe. Br J Cancer. 1996 Oct;74(8):1286-91. doi: 10.1038/bjc.1996.531. Br J Cancer. 1996. PMID: 8883419 Free PMC article. Clinical Trial.

8

Treatment with formestane alone and in combination with aminoglutethimide in heavily pretreated breast cancer patients: clinical and endocrine effects.

Geisler J, Johannessen DC, Anker G, Lønning PE. Geisler J, et al. Among authors: lonning pe. Eur J Cancer. 1996 May;32A(5):789-92. doi: 10.1016/0959-8049(95)00623-0. Eur J Cancer. 1996. PMID: 9081355 Clinical Trial.

9

Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome.

Aas T, Geisler S, Paulsen T, Børresen-Dale AL, Varhaug JE, Lønning PE, Akslen LA. Aas T, et al. Among authors: lonning pe. Acta Oncol. 1996;35 Suppl 5:5-8. doi: 10.3109/02841869609083960. Acta Oncol. 1996. PMID: 9142957

10

Differential effect of carbamazepine and valproate monotherapy on plasma levels of oestrone sulphate and dehydroepiandrosterone sulphate in male epileptic patients.

Geisler J, Engelsen BA, Berntsen H, Geisler S, Lønning PE. Geisler J, et al. Among authors: lonning pe. J Endocrinol. 1997 May;153(2):307-12. doi: 10.1677/joe.0.1530307. J Endocrinol. 1997. PMID: 9166121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

379 results

Search Page